These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22467139)

  • 1. Establishing a cancer cell in the inflammatory tissue: an epigenetic circuit.
    Mu W; Hui L
    Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):279-80. PubMed ID: 22467139
    [No Abstract]   [Full Text] [Related]  

  • 2. Vicious cycle in liver carcinogenesis: an epigenetic mirage.
    Bioulac-Sage P; Balabaud C; Chevet E
    Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):200-1. PubMed ID: 22405836
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel human hepatoma cell line, FLC-4, exhibits highly enhanced liver differentiation functions through the three-dimensional cell shape.
    Laurent T; Murase D; Tsukioka S; Matsuura T; Nagamori S; Oda H
    J Cell Physiol; 2012 Jul; 227(7):2898-906. PubMed ID: 21960466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis.
    Hatziapostolou M; Polytarchou C; Aggelidou E; Drakaki A; Poultsides GA; Jaeger SA; Ogata H; Karin M; Struhl K; Hadzopoulou-Cladaras M; Iliopoulos D
    Cell; 2011 Dec; 147(6):1233-47. PubMed ID: 22153071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transforming activity of the DNA from human hepatoma cells].
    Dukanidin EM; Serebriakova IE; Grigorian MS; Revazova ES
    Dokl Akad Nauk SSSR; 1984; 279(6):1508-10. PubMed ID: 6098435
    [No Abstract]   [Full Text] [Related]  

  • 6. Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression.
    Lazarevich NL; Shavochkina DA; Fleishman DI; Kustova IF; Morozova OV; Chuchuev ES; Patyutko YI
    Exp Oncol; 2010 Sep; 32(3):167-71. PubMed ID: 21403612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatocyte nuclear factor 4 (HNF4) in epithelial development and carcinogenesis].
    Lazarevich NL; Al'pern DV
    Mol Biol (Mosk); 2008; 42(5):786-97. PubMed ID: 18988528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
    Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
    J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors.
    Cheng Z; He Z; Cai Y; Zhang C; Fu G; Li H; Sun W; Liu C; Cui X; Ning B; Xiang D; Zhou T; Li X; Xie W; Wang H; Ding J
    Cell Res; 2019 Feb; 29(2):124-135. PubMed ID: 30560924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
    van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F
    Gastroenterology; 2008 Mar; 134(3):781-92. PubMed ID: 18325391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
    Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
    Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte iron loading capacity is associated with differentiation and repression of motility in the HepaRG cell line.
    Troadec MB; Glaise D; Lamirault G; Le Cunff M; Guérin E; Le Meur N; Détivaud L; Zindy P; Leroyer P; Guisle I; Duval H; Gripon P; Théret N; Boudjema K; Guguen-Guillouzo C; Brissot P; Léger JJ; Loréal O
    Genomics; 2006 Jan; 87(1):93-103. PubMed ID: 16325370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and signaling, complex interaction by feedback loops.
    Völler D; Bosserhoff A
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):128-30. PubMed ID: 22409367
    [No Abstract]   [Full Text] [Related]  

  • 15. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
    Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
    Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho GTPase and Wnt signaling pathways in hepatocarcinogenesis.
    Lechel A; Rudolph KL
    Gastroenterology; 2008 Mar; 134(3):875-8. PubMed ID: 18325396
    [No Abstract]   [Full Text] [Related]  

  • 17. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
    Huang X; Yu C; Jin C; Yang C; Xie R; Cao D; Wang F; McKeehan WL
    Mol Carcinog; 2006 Dec; 45(12):934-42. PubMed ID: 16929488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
    Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
    Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
    Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
    Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.